Long-term Tolerability of Ticagrelor for the Secondary Prevention of Major Adverse Cardiovascular Events : A Secondary Analysis of the PEGASUS-TIMI 54 Trial

Result code in IS VaVaI

<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00216224%3A14110%2F16%3A00091581" target="_blank" >RIV/00216224:14110/16:00091581 - isvavai.cz</a>

Result on the web

<a href="https://jamanetwork.com/journals/jamacardiology/fullarticle/2528235" target="_blank" >https://jamanetwork.com/journals/jamacardiology/fullarticle/2528235</a>

DOI - Digital Object Identifier

<a href="http://dx.doi.org/10.1001/jamacardio.2016.1017" target="_blank" >10.1001/jamacardio.2016.1017</a>

Result language

angličtina

Original language name

Long-term Tolerability of Ticagrelor for the Secondary Prevention of Major Adverse Cardiovascular Events : A Secondary Analysis of the PEGASUS-TIMI 54 Trial

Original language description

In the PEGASUS-TIMI 54 trial, treatment with ticagrelor reduced the incidence of cardiovascular death,myocardial infarction, or stroke by 15%to 16%among stable patients compared with placebo. However, more patients prematurely discontinued treatment with ticagrelor than with placebo.

Czech name

—

Czech description

—

Type

J_imp - Article in a specialist periodical, which is included in the Web of Science database

CEP classification

—

OECD FORD branch

30201 - Cardiac and Cardiovascular systems

Project

—

Continuities

I - Institucionalni podpora na dlouhodoby koncepcni rozvoj vyzkumne organizace

Publication year

2016

Confidentiality

S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Name of the periodical

JAMA Cardiology

ISSN

2380-6583

e-ISSN

—

Volume of the periodical

1

Issue of the periodical within the volume

4

Country of publishing house

US - UNITED STATES

Number of pages

8

Pages from-to

425-432

UT code for WoS article

000401895400012

EID of the result in the Scopus database

—